test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works
       

Advanced Search
Home   
 
Browse   
Communities
& Collections
  
Issue Date   
Author   
Title   
Subject   
 
Sign on to:   
Receive email
updates
  
My Account
authorized users
  
Edit Profile   
 
Help   
About T-Space   

T-Space at The University of Toronto Libraries >
University of Toronto at Scarborough >
Bioline International Legacy Collection >
Bioline International Legacy Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/8922

Title: Hypolipidemic activity of Ginkgo biloba extract, EGb 761 in hypercholesterolemic wistar rats
Authors: Dubey, Arun Kumar
Devi, Ahalya
Kutty, Gopalan
Shankar, Ravi Pathiyil
Keywords: Cardiovascular diseases, Ginkgo biloba extract, Hypolipidemic drugs, Serum Cholesterol
Issue Date: 31-Dec-2005
Publisher: Razi Institute for Drug Research (RIDR) of Iran University of Medical Sciences and Health Services (IUMS)
Citation: Iranian Journal of Pharmacology and Therapeutics (ISSN: 1735-2657) Vol 4 Num 1
Abstract: Cardiovascular diseases are becoming an increasing problem worldwide. Hypercholesterolemia has been implicated in causation of coronary heart disease. Oxidation of low density lipoprotein has been shown to be prevented by standardized Ginkgo biloba extract, EGb 761. Studies on the effect of Ginkgo biloba on serum lipid levels are lacking. Hence the present study was carried out to study the effect of EGb 761 on serum lipids in female wistar rats. The hypolipidemic effect was compared with a standard dose of lovastatin. The rats were divided into six groups of ten animals each. The first group was the normal control. The second group was given cholesterol (400 mg/kg) for 30 days. The third, fourth and fifth groups were given cholesterol and EGb 761 in the doses of 25 mg/kg, 50 mg/kg and 100 mg/kg respectively. The sixth group was given lovastatin (7.2 mg/kg) in addition to cholesterol. Serum cholesterol, triglycerides and high density lipoproteins were measured on days 0, 15 and 30. Serum levels on days 15 and 30 were compared using students paired t-test (p < 0.05). There was a significant decrease in serum cholesterol in both the lovastatin and the EGb 761 treated groups. EGb 761 did not produce a significant change in serum triglyceride and high density lipoprotein levels. The animal model used had limitations and further studies are required.
URI: http://hdl.handle.net/1807/8922
Other Identifiers: http://www.bioline.org.br/abstract?id=pt05002
Rights: Copyright 2005 - Razi Institute for Drug Research (RIDR)
Appears in Collections:Bioline International Legacy Collection

Files in This Item:

File Description SizeFormat
pt05002.pdf307.84 kBAdobe PDF
View/Open

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

uoft